rss
Ann Rheum Dis 2009;68:408-411 doi:10.1136/ard.2008.098277
  • Clinical and epidemiological research

Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis

  1. M Manetti1,2,
  2. V Liakouli3,
  3. C Fatini4,
  4. P Cipriani3,
  5. C Bonino5,
  6. S Vettori6,
  7. S Guiducci2,
  8. C Montecucco5,
  9. R Abbate4,
  10. G Valentini6,
  11. M Matucci-Cerinic2,
  12. R Giacomelli3,
  13. L Ibba-Manneschi1
  1. 1
    Department of Anatomy, Histology and Forensic Medicine, University of Florence, Florence, Italy
  2. 2
    Department of Biomedicine, Division of Rheumatology, AOUC and Excellence Centre for Research, Transfer and High Education DENOthe, University of Florence, Florence, Italy
  3. 3
    Department of Internal Medicine and Public Health, Division of Rheumatology, University of L’Aquila, L’Aquila, Italy
  4. 4
    Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Florence, Italy
  5. 5
    Division of Rheumatology, University of Pavia, IRCCS Policlinico S Matteo, Pavia, Italy
  6. 6
    Division of Rheumatology, II University of Naples, Naples, Italy
  1. Professor L Ibba-Manneschi, Department of Anatomy, Histology and Forensic Medicine, University of Florence, Viale G B Morgagni 85, 50134 Florence, Italy; ibba{at}unifi.it
  • Accepted 5 October 2008
  • Published Online First 17 October 2008

Abstract

Objective: To investigate the possible implication of SDF1-3′ polymorphism in systemic sclerosis (SSc) susceptibility or clinical phenotype, or both.

Methods: 150 patients with SSc and 150 controls were enrolled. Skin involvement, autoantibodies, interstitial lung disease, pulmonary arterial hypertension (PAH), scleroderma renal crisis, past and/or current skin ulcers were assessed. Genotyping was performed by PCR-RFLP.

Results: Genotype distribution and allele frequency were similar in SSc and controls. SDF1-3′A allele and SDF1-3′GA/AA genotype frequencies were significantly higher in SSc-PAH than in SSc-non-PAH (33.3% vs 18.3%, p = 0.01) and in SSc with skin ulcers than in SSc without ulcers (27.3% vs 16.9%, p = 0.03). The SDF1-3′A allele influenced the predisposition to SSc-related PAH (OR = 2.52, 95% CI 1.11 to 5.69, p = 0.02) and skin ulcers (OR = 2.31, 95% CI 1.18 to 4.52, p = 0.01). After adjustment for age and gender, the SDF1-3′A allele remained a susceptibility factor for the SSc-related vascular manifestations (PAH: OR = 2.37, 95% CI 1.04 to 5.42, p = 0.04; ulcers: OR = 2.33, 95% CI 1.78 to 4.62, p = 0.01).

Conclusion: The SDF1-3′A allele is significantly associated with microvascular involvement in SSc.

Footnotes

  • Competing interests: None.

  • Funding: This study has been supported by grants from the Ministero Italiano dell’Università e della Ricerca (MIUR) and the Associazione per lo studio della Sclerosi Sistemica e delle Malattie Fibrosanti (ASSMaF onlus).

  • Ethics approval: Approved by the local ethics committees.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. ard.2008.098277v1
    2. 68/3/408 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.